Abcam Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | Abcam PLC

Abcam PLC | Ownership

Companies that own Abcam PLC

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

T. Rowe Price Associates, Inc.

22,086,486

10.77%

-543,368

0.06%

05/04/2018

Baillie Gifford & Co.

10,792,846

5.26%

-2,167,109

0.13%

05/10/2018

Wasatch Advisors, Inc.

10,722,824

5.23%

-588,109

1.38%

02/28/2018

Select Equity Group LP

9,693,955

4.73%

-3,425,738

1.06%

09/07/2017

Harding Loevner LP

8,054,591

3.93%

1,908,782

0.39%

05/03/2018

OppenheimerFunds, Inc.

7,683,310

3.75%

47,100

0.09%

05/02/2018

Woodford Investment Management Ltd.

5,906,000

2.88%

114,000

0.8%

08/01/2018

Standard Life Investments Ltd.

5,879,036

2.87%

-349,450

0.19%

05/03/2018

T. Rowe Price International Ltd.

5,867,445

2.86%

-1,002,239

0.22%

06/30/2018

Octopus Investments Ltd.

5,701,634

2.78%

53,634

4.9%

05/08/2018

About Abcam

View Profile

Address	330 Cambridge Science Park Cambridge East Anglia CB4 0FL United Kingdom
Employees	-
Website	http://abcam.com
Updated	07/08/2019
Abcam Plc distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. The company was founded by Adam Robert David Cleevely, Anthony Kouzarides and Jonathan Milner on February 12, 1998 and is headquartered in Cambridge, the United Kingdom.